Compare iShares MSCI India ETF (INDA) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI India ETF vs Procter & Gamble Co — how do they compare? iShares MSCI India ETF trades at $45.89 (market cap $5.81B), while Procter & Gamble Co trades at $150.16 (market cap $343.34B). The key difference: Procter & Gamble Co is far larger — about 59.1× iShares MSCI India ETF's market cap, and Procter & Gamble Co pays a 2.95% dividend while iShares MSCI India ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 57 Days and Procter & Gamble Co for 131 Days on average.
| INDA | PG | |
|---|---|---|
Market Cap | $5.81B | $343.34B |
Volume | 5,590,429 | 8,662,344 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $55.29 | $167.18 |
52-Week Low | $45.42 | $138.10 |
Typical Hold Time | 57 Days | 131 Days |
Enterprise Value | — | $369.18B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INDA is trading at $46.12, down 1.31% with a bearish technical signal across moving averages and oscillators. The ETF faces headwinds from India's economic challenges including coal power shortages, below-average monsoon rains, and pharmaceutical sector export issues. Technical indicators show oversold conditions with RSI readings below 30, while support and resistance cluster around $46.
The outlook remains cautious given India's infrastructure constraints and global trade tensions. Investment opportunity exists for long-term exposure to India's growth story, but risks include energy security concerns, weather-related agricultural impacts, and IT sector weakness. Current technical oversold conditions may present entry points for patient investors.
Procter & Gamble (PG) trades at $147.82, down 0.4% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $1.88. Strong fundamentals include $84.28B revenue, 18.44% net margin, and robust cash flow generation. Recent developments include a WNBA partnership and a dividend declaration of $1.09 payable in August 2026.
PG offers stable growth with premium valuation metrics (P/E 22.33, P/S 4.11) supported by strong brand equity and dividend consistency. Risks include premium valuation concerns amid modest growth outlook and competitive pressures. Analyst consensus is bullish with a $160.13 price target, though near-term upside may be limited given current price proximity to the lower target range.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
